FierceBiotech ٢٠ فبراير ٢٠٢٦ Candel glows brighter with $100M RTW royalty deal to fund prostate cancer drug's launch
FierceBiotech ١٩ فبراير ٢٠٢٦ White House frustration may have fueled FDA’s Moderna walkback: Politico
FierceBiotech ١٩ فبراير ٢٠٢٦ Sanofi backs Altesa's $75M series B to bankroll antiviral's midstage rhinovirus study
FierceBiotech ١٩ فبراير ٢٠٢٦ J&J halts enrollment in phase 2 trial of AC Immune-partnered Alzheimer's therapy
FierceBiotech ١٩ فبراير ٢٠٢٦ GSK strikes 5-year deal with Jackson Laboratory focused on neurodegenerative disease research
FierceBiotech ١٩ فبراير ٢٠٢٦ NIH Director Jay Bhattacharya to take over as temporary CDC chief: media reports
FierceBiotech ١٨ فبراير ٢٠٢٦ Blood from pediatricians yields potential new medicines for respiratory viruses
FierceBiotech ١٨ فبراير ٢٠٢٦ Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal
FierceBiotech ١٨ فبراير ٢٠٢٦ Sensei steps back from brink by finding Faeth and its phase 2-stage cancer drug
FierceBiotech ١٨ فبراير ٢٠٢٦ Gut-focused Rasayana ingests gastrointestinal candidate in $36M licensing deal
FierceBiotech ١٨ فبراير ٢٠٢٦ Lilly pays CSL $100M upfront for IL-6 antibody that flunked a phase 3 organ transplant study
FierceBiotech ١٨ فبراير ٢٠٢٦ Korsana crosses into crowded Alzheimer's field with $175M and anti-amyloid antibody